Latest Insider Transactions at Equillium, Inc. (EQ)
This section provides a real-time view of insider transactions for Equillium, Inc. (EQ). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Equillium, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Equillium, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 28
2024
|
Christine Zedelmayer Sr. Vice President and COO |
SELL
Open market or private sale
|
Direct |
15,000
-9.98%
|
$15,000
$1.25 P/Share
|
|
Oct 28
2024
|
Penny Tom Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,835
-30.26%
|
$2,835
$1.25 P/Share
|
|
Oct 25
2024
|
Penny Tom Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
683
-6.8%
|
$683
$1.25 P/Share
|
|
Sep 26
2024
|
Jason A Keyes Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-14.77%
|
$0
$0.81 P/Share
|
|
Sep 16
2024
|
Penny Tom Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
38,806
-79.43%
|
$0
$0.85 P/Share
|
|
Jul 16
2024
|
Jason A Keyes Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-12.87%
|
$0
$0.87 P/Share
|
|
Dec 08
2023
|
Jason A Keyes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,805
+13.0%
|
$0
$0.58 P/Share
|
|
Dec 08
2023
|
Christine Zedelmayer Sr. Vice President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
8,804
+6.11%
|
$0
$0.58 P/Share
|
|
Dec 08
2023
|
Joel Rothman Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,804
+13.15%
|
$0
$0.58 P/Share
|
|
Jun 09
2023
|
Jason A Keyes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+23.04%
|
$0
$0.56 P/Share
|
|
Jun 09
2023
|
Christine Zedelmayer Sr. Vice President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+10.61%
|
$0
$0.56 P/Share
|
|
Jun 09
2023
|
Joel Rothman Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+23.31%
|
$0
$0.56 P/Share
|
|
Dec 09
2022
|
Jason A Keyes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,444
+11.24%
|
$4,444
$1.19 P/Share
|
|
Dec 09
2022
|
Joel Rothman Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,821
+10.01%
|
$3,821
$1.19 P/Share
|
|
Aug 29
2022
|
Jason A Keyes Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
7,000
-8.26%
|
$14,000
$2.83 P/Share
|
|
Jun 10
2022
|
Christine Zedelmayer Sr. Vice President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
9,033
+7.5%
|
$9,033
$1.85 P/Share
|
|
Jun 10
2022
|
Joel Rothman Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,244
+16.98%
|
$6,244
$1.85 P/Share
|
|
Jun 06
2022
|
Jason A Keyes Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
5,000
-5.57%
|
$10,000
$2.52 P/Share
|
|
Apr 04
2022
|
Jason A Keyes Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
8,000
-8.19%
|
$24,000
$3.18 P/Share
|
|
Dec 10
2021
|
Joel Rothman Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,290
+5.04%
|
$2,580
$2.35 P/Share
|
|
Dec 10
2021
|
Jason A Keyes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,585
+19.34%
|
$11,170
$2.35 P/Share
|
|
Dec 01
2021
|
Jason A Keyes Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
5,000
-4.87%
|
$25,000
$5.08 P/Share
|
|
Nov 16
2021
|
Christine Zedelmayer Sr. Vice President and COO |
SELL
Open market or private sale
|
Direct |
11,434
-5.41%
|
$57,170
$5.49 P/Share
|
|
Nov 16
2021
|
Christine Zedelmayer Sr. Vice President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
23,334
+9.9%
|
$46,668
$2.45 P/Share
|
|
Oct 06
2021
|
Stephen Connelly Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,092
-0.41%
|
$56,644
$7.01 P/Share
|
|
Oct 06
2021
|
Stephen Connelly Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,092
+0.4%
|
$24,276
$3.78 P/Share
|
|
Sep 27
2021
|
Jason A Keyes Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
8,000
-7.23%
|
$48,000
$6.74 P/Share
|
|
Jul 27
2021
|
Jason A Keyes Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
5,000
-4.32%
|
$25,000
$5.72 P/Share
|
|
Jun 10
2021
|
Joel Rothman Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,742
+25.19%
|
$15,484
$2.35 P/Share
|
|
Jun 10
2021
|
Jason A Keyes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,535
+23.81%
|
$11,070
$2.35 P/Share
|
|
Jun 10
2021
|
Christine Zedelmayer Sr. Vice President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
9,032
+9.07%
|
$18,064
$2.35 P/Share
|
|
Jun 08
2021
|
Stephen Connelly Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,495
-1.05%
|
$73,465
$7.18 P/Share
|
|
Jun 08
2021
|
Stephen Connelly Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,495
+1.04%
|
$41,980
$4.75 P/Share
|
|
Jun 07
2021
|
Stephen Connelly Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
22,390
-1.11%
|
$156,730
$7.11 P/Share
|
|
Jun 07
2021
|
Stephen Connelly Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,390
+1.1%
|
$67,170
$3.78 P/Share
|
|
Jun 04
2021
|
Stephen Connelly Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
13,539
-0.68%
|
$94,773
$7.01 P/Share
|
|
Jun 04
2021
|
Stephen Connelly Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,539
+0.67%
|
$40,617
$3.78 P/Share
|
|
May 26
2021
|
Jason A Keyes Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
5,000
-4.14%
|
$30,000
$6.5 P/Share
|
|
Dec 28
2020
|
Stephen Connelly Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.46%
|
$100,000
$4.52 P/Share
|
|
Dec 23
2020
|
Jason A Keyes Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
8,000
-6.22%
|
$32,000
$4.74 P/Share
|
|
Dec 10
2020
|
Christine Zedelmayer Sr. Vice President and COO |
BUY
Other acquisition or disposition
|
Direct |
1,097
+1.33%
|
$2,194
$2.35 P/Share
|
|
Dec 10
2020
|
Jason A Keyes Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
5,362
+30.57%
|
$10,724
$2.35 P/Share
|
|
Sep 28
2020
|
Stephen Connelly Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.4%
|
$125,000
$5.62 P/Share
|